Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HCW Biologics (HCWB) Cost of Revenue (2022 - 2025)

Historic Cost of Revenue for HCW Biologics (HCWB) over the last 4 years, with Q3 2025 value amounting to $12485.0.

  • HCW Biologics' Cost of Revenue fell 9634.02% to $12485.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $337620.0, marking a year-over-year decrease of 8571.16%. This contributed to the annual value of $1.6 million for FY2024, which is 2954.48% down from last year.
  • Per HCW Biologics' latest filing, its Cost of Revenue stood at $12485.0 for Q3 2025, which was down 9634.02% from $5240.0 recorded in Q2 2025.
  • HCW Biologics' Cost of Revenue's 5-year high stood at $1.4 million during Q3 2022, with a 5-year trough of $4052.0 in Q1 2025.
  • Its 4-year average for Cost of Revenue is $536420.8, with a median of $438443.0 in 2024.
  • Per our database at Business Quant, HCW Biologics' Cost of Revenue skyrocketed by 164434.41% in 2024 and then plummeted by 9920.85% in 2025.
  • Quarter analysis of 4 years shows HCW Biologics' Cost of Revenue stood at $1.1 million in 2022, then fell by 0.17% to $1.1 million in 2023, then plummeted by 70.52% to $315843.0 in 2024, then tumbled by 96.05% to $12485.0 in 2025.
  • Its Cost of Revenue stands at $12485.0 for Q3 2025, versus $5240.0 for Q2 2025 and $4052.0 for Q1 2025.